KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCapital ExpendituresCapital ExpendituresCash from Discontinued OperationsCash from Discontinued OperationsCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMD) Capital Expenditures (2020 - 2025)

LifeMD filings provide 6 years of Capital Expenditures readings, the most recent being -$6.6 million for Q4 2025.

  • On a quarterly basis, Capital Expenditures fell 220.14% to -$6.6 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.9 million, a 72.24% decrease, with the full-year FY2025 number at $1.9 million, down 72.24% from a year prior.
  • Capital Expenditures hit -$6.6 million in Q4 2025 for LifeMD, down from $2.8 million in the prior quarter.
  • In the past five years, Capital Expenditures ranged from a high of $6.2 million in Q3 2023 to a low of -$6.6 million in Q4 2025.
  • Median Capital Expenditures over the past 5 years was $148901.5 (2024), compared with a mean of $868282.2.
  • Biggest five-year swings in Capital Expenditures: plummeted 10335.01% in 2022 and later soared 14058.03% in 2024.
  • LifeMD's Capital Expenditures stood at -$61105.0 in 2021, then plummeted by 10335.01% to -$6.4 million in 2022, then skyrocketed by 133.05% to $2.1 million in 2023, then surged by 159.73% to $5.5 million in 2024, then plummeted by 220.14% to -$6.6 million in 2025.
  • The last three reported values for Capital Expenditures were -$6.6 million (Q4 2025), $2.8 million (Q3 2025), and $5.5 million (Q2 2025) per Business Quant data.